Arkolith/Insider Trading/SBTX/Form 4

Root Jonathan D

DirectorSilverback Therapeutics, Inc. (SBTX) · full profile →Form 4 · filed Dec 15, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 13, 2021Other(J)105K——0
Dec 13, 2021Other(J)2.1M——0

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-21-012894) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML